Table 1 Characteristics of the patients
Characteristics | DLBCL (n = 42) | BL (n = 29) | PBL and IBL (n = 6) |
|---|---|---|---|
Age (years) | |||
Median | 44 | 54 | 48 |
Range | 24–73 | 25–73 | 33–74 |
P = 0.151 | |||
Gender (%) | |||
Male | 37 (88.1) | 27 (93.1) | 5 (83.3) |
Female | 5 (11.9) | 2 (6.9) | 1 (6.7) |
P = 0.692 | |||
Ann Arbor stage (%) | |||
I, II | 23 (54.8) | 10 (34.5) | 3 (50.0) |
III, IV | 19 (45.2) | 19 (65.5) | 3 (50.0) |
P = 0.146 | |||
Extranodal diseases (%) | |||
0,1 | 33 (78.6) | 15 (51.7) | 4 (66.7) |
> 1 | 9 (21.4) | 14 (48.3) | 2 (33.3) |
P = 0.004 | |||
LDH | |||
Median | 334 | 373 | 283 |
Range | 139–6016 | 178–5009 | 182–739 |
P = 0.257 | |||
ECOG score (%) | |||
0,1 | 18 (42.9) | 5 (17.2) | 3 (50.0) |
> 1 | 24 (57.1) | 24 (82.8) | 3 (50.0) |
P = 0.038 | |||
IPI (%) | |||
0,1 | 16 (38.1) | 5 (17.2) | 3 (50.0) |
> 1 | 26 (61.9) | 24 (82.8) | 3 (50.0) |
P = 0.069 | |||
CD4 cell count | |||
Median | 106 | 108 | 31 |
Range | 4–483 | 1–549 | 3–69 |
P = 0.526 | |||